Risk Factors for Symptomatic Recurrence after Laparoscopic Adenomyomectomy: A 3-Year Follow-up.

Feng Sun,Jin Yu,YiLian Pan,XiaoNa Huo,YePing Yang,Hong Xu
DOI: https://doi.org/10.1016/j.jmig.2023.03.001
IF: 4.314
2023-01-01
Journal of Minimally Invasive Gynecology
Abstract:Study Objective: To identify the clinical risk factors for symptomatic recurrence of adenomyosis after laparoscopic adeno-myomectomy with a three-year follow-up.Design: Retrospective study.Setting: University-affiliated hospital.Patients: A total of 149 patients were included in this study, including 52 patients with symptomatic recurrence and 97 without recurrence. Intervention: Laparoscopic adenomyomectomy was performed first. Measurements and Main Results: General clinical data, including preoperative, intraoperative, and postoperative indices, symptomatic recurrence, and follow-up information, were collected. Comparison of women with and without symptomatic recurrence revealed significant differences for age at surgery (p = .026), presence of concomitant ovarian endometrioma (p <.001), and prescription of postoperative hormonal suppression (yes/no) (p <.0001). A Cox proportional hazard model indicated that concomitant ovarian endometrioma was a significant risk factor for recurrence (hazard ratio [HR], 2.06; 95% confidence interval [CI], 1.10-3.85, p = .001). Patients who received postoperative hormonal suppression had a lower risk of recurrence than those without hormonal suppression (HR, 0.30; 95% CI, 0.16-0.55, p <.0001). Those aged >40 years also had a lower risk of symptomatic recurrence than those <40 years (HR, 0.46; 95% CI, 0.24-0.88, p = .03).Conclusions: Concomitant ovarian endometrioma is a risk factor for symptomatic recurrence of adenomyosis after laparo-scopic adenomyomectomy. Postoperative hormonal suppression and older age at surgery (>40 years) are protective factors. Journal of Minimally Invasive Gynecology (2023) 30, 555-561. & COPY; 2023 AAGL. All rights reserved.
What problem does this paper attempt to address?